Granules forges strategic partnership with Greenko ZeroC for Kakinada plant

Under the collaboration, Greenko ZeroC will be supplying carbon free energy and enable green hydrogen along with its various chemical derivatives

Granules India
Granules India
BS Web Team New Delhi
2 min read Last Updated : Jan 03 2023 | 3:24 PM IST
Drug maker Granules India on Tuesday said that it has entered into a strategic partnership with Greenko ZeroC to develop and promote carbon-free energy and green molecule solutions.

According to the company’s statement, the firm entered into the partnership to “collaborate for Green Molecule Solutions and its wider applications in pharmaceuticals to build a leadership position in sustainability and circular economy initiatives and be a pioneer in the industry.”

In a first-of-its-kind collaboration, the companies will be developing and promoting “state-of-the-art Integrated Green Pharmaceutical Zones (GPZ)” in Andhra Pradesh’s Kakinada. The facility would be spread across 100 acres for the project with an estimated cost of approximately Rs 2,000 crore over five years.

Granules informed that it will be building a green field facility based on sustainability principles for large-scale manufacturing of key starting materials (KSMs), Intermediates, APIs and fermentation-based products.

Under the collaboration, Greenko ZeroC will be supplying carbon-free energy and enable green hydrogen along with its various chemical derivatives. Granules plans to utilise them to produce value-added products such as DCDA, PAP, Paracetamol, Metformin, other APIs, and Intermediates.

“Granules will also manufacture energy-intensive fermentation-based products at this facility using carbon-free energy. This collaboration allows utilization of Fungible Carbon Offset instruments across Granules global manufacturing locations,” the company said.

Commenting on the partnership, the Chairman and Managing Director of Granules Dr Krishna Prasad said that it will power Granules’ sustainability journey by minimizing carbon footprint and impact of their operations on the environment.

“Sustainability and green chemistry are key pillars of our commitment to heal the planet and people through minimizing carbon footprint, adopting resource-efficient processes, and reduce waste across our value chain,” he added.

Greenko CEO and Managing Director Anil Kumar Chalamalasetty called the collaboration an innovative and pioneering one, which “will propel the transformation of industrial manufacturing to be more sustainable and competitive with technologically superior and green solutions.”

“Such partnerships will enable PM Modi Ji’s vision of India’s leadership in the global efforts to combat Climate Change and catalyze India’s and the world’s decarbonisation,” he added.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Granules Indiapharmaceutical firms

Next Story